Literature DB >> 35034261

Traumatic optic neuropathy: a review of current studies.

Bin Chen1,2, Hengsen Zhang1,2, Qing Zhai2, Huaipeng Li3, Chunxia Wang4, Yong Wang5.   

Abstract

Traumatic optic neuropathy (TON) is a serious complication of craniofacial trauma that directly or indirectly damages the optic nerve and can cause severe vision loss. The incidence of TON has been gradually increasing in recent years. Research on the protection and regeneration of the optic nerve after the onset of TON is still at the level of laboratory studies and which is insufficient to support clinical treatment of TON. And, due to without clear guidelines, there is much ambiguity regarding its diagnosis and management. Clinical interventions for TON include observation only, treatment with corticosteroids alone, or optic canal (OC) decompression (with or without steroids). There is controversy in clinical practice concerning which treatment is the best. A review of available studies shows that the visual acuity of patients with TON can be significantly improved after OC decompression surgery (especially endoscopic transnasal/transseptal optic canal decompression (ETOCD)) with or without the use of corticosteroids. And new findings of laboratory studies such as mitochondrial therapy, lipid change studies, and other studies in favor of TON therapy have also been identified. In this review, we discuss the evolving perspective of surgical treatment and experimental study.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Corticosteroids therapy; Diagnosis; Neuroprotection and neuroregeneration; Optic nerve decompression; Traumatic optic neuropathy

Year:  2022        PMID: 35034261     DOI: 10.1007/s10143-021-01717-9

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  189 in total

Review 1.  Inflammation and axon regeneration.

Authors:  Larry I Benowitz; Phillip G Popovich
Journal:  Curr Opin Neurol       Date:  2011-12       Impact factor: 5.710

Review 2.  Degenerative and regenerative responses of injured neurons in the central nervous system of adult mammals.

Authors:  A J Aguayo; M Rasminsky; G M Bray; S Carbonetto; L McKerracher; M P Villegas-Pérez; M Vidal-Sanz; D A Carter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1991-03-29       Impact factor: 6.237

Review 3.  Regeneration of axons in the visual system.

Authors:  Martin Berry; Zubair Ahmed; Barbara Lorber; Michael Douglas; Ann Logan
Journal:  Restor Neurol Neurosci       Date:  2008       Impact factor: 2.406

4.  Trk receptors function as rapid retrograde signal carriers in the adult nervous system.

Authors:  A Bhattacharyya; F L Watson; T A Bradlee; S L Pomeroy; C D Stiles; R A Segal
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 5.  Polyunsaturated fatty acids and their metabolites in brain function and disease.

Authors:  Richard P Bazinet; Sophie Layé
Journal:  Nat Rev Neurosci       Date:  2014-11-12       Impact factor: 34.870

6.  A multivariate logistic regression analysis of risk factors for blunt cerebrovascular injury.

Authors:  John D Berne; Alan Cook; Stephen A Rowe; Scott H Norwood
Journal:  J Vasc Surg       Date:  2009-12-02       Impact factor: 4.268

7.  A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.

Authors:  R W Beck; P A Cleary; M M Anderson; J L Keltner; W T Shults; D I Kaufman; E G Buckley; J J Corbett; M J Kupersmith; N R Miller
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

8.  The characteristics of midfacial fractures and the association with ocular injury: a prospective study.

Authors:  I A al-Qurainy; L F Stassen; G N Dutton; K F Moos; A el-Attar
Journal:  Br J Oral Maxillofac Surg       Date:  1991-10       Impact factor: 1.651

Review 9.  Retinal regeneration mechanisms linked to multiple cancer molecules: A therapeutic conundrum.

Authors:  Amanda Barber; Kyle Farmer; Keith R Martin; Patrice D Smith
Journal:  Prog Retin Eye Res       Date:  2016-08-30       Impact factor: 21.198

10.  Protective effect of etanercept, an inhibitor of tumor necrosis factor-α, in a rat model of retinal ischemia.

Authors:  Hyoung Won Bae; Naeun Lee; Gong Je Seong; Seungsoo Rho; Samin Hong; Chan Yun Kim
Journal:  BMC Ophthalmol       Date:  2016-06-04       Impact factor: 2.209

View more
  1 in total

1.  High-Mobility Group Box 1 Inhibitor BoxA Alleviates Neuroinflammation-Induced Retinal Ganglion Cell Damage in Traumatic Optic Neuropathy.

Authors:  Jingyi Peng; Jiayi Jin; Wenru Su; Wanwen Shao; Weihua Li; Zhiquan Li; Huan Yu; Yongxin Zheng; Liuxueying Zhong
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.